Skip to main content
Caplight Logo









Mentara Bio Inc.

Mentara Bio Inc.

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://mentarabio.com/

Last Round

Series B

May 1, 2024

Total Funding Raised

$10.2M

Company Overview

Mentara Bio Inc. is a biotechnology company that develops innovative therapies for neurological disorders, including epilepsy and Dravet syndrome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoveryCNS disordersprecision medicinesmall-moleculeclinical trialsbiotechNMDA receptor antagonistglutamate pathwayneurological disordersepilepsy treatmentdrug pipelinetherapeutic developmentcentral nervous systembiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mentara Bio Inc. Comparables

Compare Mentara Bio Inc. with similar companies based on industry and business-model similarity.

Mentara Bio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Engrail Therapeutics
78%
Praxis Precision Medicines, Inc.
75%
H. Lundbeck A/S
74%

Mentara Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 1, 2024
Series AMar 6, 2023
GrantFeb 15, 2022
Series ADec 13, 2021

Key People

Founding team and executive leadership

Sahil V.

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Monthly visitors grew 122% MoM, reaching 1.3K.

  • Nov 8, 2025

    Monthly visitors increased 35% MoM.

Mentara Bio Inc. Filings

Explore SEC and related filing metadata, where available.

Mentara Bio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mentara Bio Inc.'s valuation, stock price, and market status.

Is Mentara Bio Inc. a public or private company?

Mentara Bio Inc. is a private company.

What is the current stock price of Mentara Bio Inc.?

Mentara Bio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Mentara Bio Inc. worth (valuation)?

Valuation information for Mentara Bio Inc. is not publicly available.

Can I buy Mentara Bio Inc. stock?

Mentara Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mentara Bio Inc.'s last funding round?

Mentara Bio Inc.'s most recent funding round was Grant on February 15, 2022.

Who are the main investors in Mentara Bio Inc.?

Investor information for Mentara Bio Inc. is not publicly disclosed.

Will Mentara Bio Inc. IPO soon?

No public IPO plans have been announced for Mentara Bio Inc..

How can I track Mentara Bio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mentara Bio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range2
Year Founded2022
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?